Theratechnologies to Present Safety and Efficacy Data of Ibalizumab

Theratechnologies announced the presentation of abstract on safety data from Ibalizumab at an upcoming conference.

Theratechnologies (TSX:TH) announced the presentation of abstract on safety data from Ibalizumab at an upcoming conference.
As quoted in the press release:

Dr. Brinda Emu, Assistant Professor of Medicine, Infectious Diseases, Yale School of Medicine, New Haven, CT will be presenting detailed data related to the long-term efficacy and safety of ibalizumab, an investigational drug. The presentation will be held during the afternoon session on October 6, 2017, entitled Modern ART.

Click here to read the full press release.